Anchor Capital Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$865K Hold
721
0.02% 182
2026
Q1
$663K Hold
721
0.02% 186
2025
Q4
$775K Sell
721
-38
-5% -$36.3K 0.02% 188
2025
Q3
$579K Sell
759
-8
-1% -$5.95K 0.02% 199
2025
Q2
$598K Hold
767
0.02% 198
2025
Q1
$633K Hold
767
0.02% 191
2024
Q4
$592K Hold
767
0.02% 204
2024
Q3
$680K Hold
767
0.02% 191
2024
Q2
$694K Hold
767
0.02% 185
2024
Q1
$597K Hold
767
0.02% 195
2023
Q4
$447K Hold
767
0.01% 205
2023
Q3
$412K Hold
767
0.01% 221
2023
Q2
$360K Sell
767
-708
-48% -$297K 0.01% 231
2023
Q1
$507K Hold
1,475
0.01% 217
2022
Q4
$540K Hold
1,475
0.01% 216
2022
Q3
$477K Hold
1,475
0.01% 216
2022
Q2
$478K Hold
1,475
0.01% 222
2022
Q1
$422K Hold
1,475
0.01% 232
2021
Q4
$407K Hold
1,475
0.01% 233
2021
Q3
$341K Sell
1,475
-50
-3% -$12.3K 0.01% 237
2021
Q2
$350K Sell
1,525
-25
-2% -$5.02K 0.01% 238
2021
Q1
$290K Hold
1,550
0.01% 245
2020
Q4
$262K Sell
1,550
-10
-0.6% -$1.49K 0.01% 241
2020
Q3
$231K Hold
1,560
0.01% 244
2020
Q2
$256K Sell
1,560
-10
-0.6% -$1.53K 0.01% 232
2020
Q1
$218K Sell
1,570
-30
-2% -$4.12K 0.01% 230
2019
Q4
$210K Buy
+1,600
New +$185K ﹤0.01% 249
2019
Q2
Sell
-1,750
Closed -$227K 249
2019
Q1
$227K Hold
1,750
﹤0.01% 240
2018
Q4
$203K Buy
+1,750
New +$195K 0.01% 264

Other funds holding LLY

Anchor Capital Advisors's LLY Position: Q2 2026 in Review

Anchor Capital Advisors held its Eli Lilly (LLY) position steady in Q2 2026 at 721 shares worth $865K. The position accounts for 0.02% of the portfolio, ranked #182.

Anchor Capital Advisors first reported a position in LLY in Q4 2018 and has held it in 29 quarters since. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Anchor Capital Advisors held 721 shares of Eli Lilly worth $865K as of Q2 2026.
  • Anchor Capital Advisors left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.02% of Anchor Capital Advisors's portfolio in Q2 2026, its #182 holding.
  • Anchor Capital Advisors first reported a position in Eli Lilly in Q4 2018 and has held it in 29 quarters since.
  • 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Anchor Capital Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.